Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

592 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarians.
Vijayakumar M, Lemos PA, Hoye A, Ong AT, Aoki J, Granillo GR, McFadden EP, Sianos G, Hofma SH, Smits PC, van der Giessen WJ, de Feyter P, van Domburg RT, Cummins PA, Serruys PW. Vijayakumar M, et al. Among authors: van domburg rt, van der giessen wj. Am J Cardiol. 2004 Oct 1;94(7):909-13. doi: 10.1016/j.amjcard.2004.06.036. Am J Cardiol. 2004. PMID: 15464675
Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era.
Meliga E, García-García HM, Kukreja N, Daemen J, Tanimoto S, Ramcharitar S, van Mieghem CA, Sianos G, van der Ent M, van der Giessen WJ, de Feyter P, van Domburg R, Serruys PW. Meliga E, et al. Catheter Cardiovasc Interv. 2007 Jul 1;70(1):21-5. doi: 10.1002/ccd.21100. Catheter Cardiovasc Interv. 2007. PMID: 17584913
Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry.
Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, Cook S, Reardon L, Moretti C, De Servi S, Palacios IF, Windecker S, Colombo A, van Domburg R, Sheiban I, Serruys PW; DELFT (Drug Eluting stent for LeFT main) Registry. Meliga E, et al. J Am Coll Cardiol. 2008 Jun 10;51(23):2212-9. doi: 10.1016/j.jacc.2008.03.020. J Am Coll Cardiol. 2008. PMID: 18534266 Free article.
The everolimus-eluting stent in real-world patients: 6-month follow-up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) registry.
Onuma Y, Kukreja N, Piazza N, Eindhoven J, Girasis C, Schenkeveld L, van Domburg R, Serruys PW; Interventional Cardiologists of the Thoraxcenter (2000 to 2007). Onuma Y, et al. J Am Coll Cardiol. 2009 Jul 14;54(3):269-76. doi: 10.1016/j.jacc.2009.05.016. J Am Coll Cardiol. 2009. PMID: 19589442 Free article.
Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
Simsek C, Magro M, Boersma E, Onuma Y, Nauta S, Daemen J, Gaspersz M, van Geuns RJ, van der Giessen W, van Domburg R, Serruys P. Simsek C, et al. J Invasive Cardiol. 2011 Aug;23(8):336-41. J Invasive Cardiol. 2011. PMID: 21828397
592 results